THE ROLE OF NUCLEAR FACTOR NFIB-MEDIATED NAD METABOLISM REPROGRAMMING IN THE DEVELOPMENT AND PROGRESSION OF COLORECTAL CANCER

被引：0
|
作者：
Zhou, Zhi-hang
Mao, Lin-hong
Li, Xiao-qin
He, Song
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
868
引用
收藏
页码：S194 / S195
页数：2
相关论文
共 50 条
  • [1] NFIB-Mediated Repression of the Epigenetic Factor Ezh2 Regulates Cortical Development
    Piper, Michael
    Barry, Guy
    Harvey, Tracey J.
    McLeay, Robert
    Smith, Aaron G.
    Harris, Lachlan
    Mason, Sharon
    Stringer, Brett W.
    Day, Bryan W.
    Wray, Naomi R.
    Gronostajski, Richard M.
    Bailey, Timothy L.
    Boyd, Andrew W.
    Richards, Linda J.
    JOURNAL OF NEUROSCIENCE, 2014, 34 (08): : 2921 - 2930
  • [2] Hepatocyte Nuclear Factor 3β Plays a Suppressive Role in Colorectal Cancer Progression
    Wang, Juan
    Lu, Hao
    Wang, Wei
    Zheng, Nanxin
    Wang, Yi
    Hu, Zhiqian
    Ji, Gang
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [3] PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
    Dai, Weixing
    Xiang, Wenqiang
    Han, Lingyu
    Yuan, Zixu
    Wang, Renjie
    Ma, Yanlei
    Yang, Yongzhi
    Cai, Sanjun
    Xu, Ye
    Mo, Shaobo
    Li, Qingguo
    Cai, Guoxiang
    CANCER COMMUNICATIONS, 2022, 42 (09) : 848 - 867
  • [4] METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
    Wei Wei
    Zhong-Yuan Zhang
    Bin Shi
    Yike Cai
    Hou-Shun Zhang
    Chun-Lei Sun
    Yun-Fei Fei
    Wen Zhong
    Shuang Zhang
    Chen Wang
    Bing He
    Guan-Min Jiang
    Hao Wang
    Journal of Experimental & Clinical Cancer Research, 42
  • [5] METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
    Wei, Wei
    Zhang, Zhong-Yuan
    Shi, Bin
    Cai, Yike
    Zhang, Hou-Shun
    Sun, Chun-Lei
    Fei, Yun-Fei
    Zhong, Wen
    Zhang, Shuang
    Wang, Chen
    He, Bing
    Jiang, Guan-Min
    Wang, Hao
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [6] Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance
    Qin, Rong
    Fan, Xirui
    Huang, Yun
    Chen, Sijing
    Ding, Rui
    Yao, Ying
    Wu, Rui
    Duan, Yiyao
    Li, Xiang
    Khan, Hameed Ullah
    Hu, Jun
    Wang, Hui
    TRANSLATIONAL ONCOLOGY, 2024, 50
  • [7] Matairesinol Nanoparticles Restore Chemosensitivity and Suppress Colorectal Cancer Progression in Preclinical Models: Role of Lipid Metabolism Reprogramming
    Wu, Shenshen
    Wang, Jiajia
    Fu, Zan
    Familiari, Giuseppe
    Relucenti, Michela
    Aschner, Michael
    Li, Xiaobo
    Chen, Rui
    Chen, Hanqing
    NANO LETTERS, 2023, 23 (05) : 1970 - 1980
  • [8] Role of PKC in the development and progression of colorectal cancer
    Batlle, E
    Baulida, J
    Franci, C
    Verdú, X
    de Herreros, AG
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S43 - S43
  • [9] Role of cMET in the Development and Progression of Colorectal Cancer
    Samame Perez-Vargas, Juan Carlos
    Biondani, Pamela
    Maggi, Claudia
    Gariboldi, Manuela
    Gloghini, Annunziata
    Inno, Alessandro
    Volpi, Chiara Costanza
    Gualeni, Ambra Vittoria
    di Bartolomeo, Maria
    de Braud, Filippo
    Castano, Alessandra
    Bossi, Ilaria
    Pietrantonio, Filippo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (09) : 18056 - 18077
  • [10] Correction: METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
    Wei Wei
    Zhong-Yuan Zhang
    Bin Shi
    Yike Cai
    Hou-Shun Zhang
    Chun-Lei Sun
    Yun-Fei Fei
    Wen Zhong
    Shuang Zhang
    Chen Wang
    Bing He
    Guan-Min Jiang
    Hao Wang
    Journal of Experimental & Clinical Cancer Research, 43
12345